[HTML][HTML] The antimicrobial peptides and their potential clinical applications
J Lei, L Sun, S Huang, C Zhu, P Li, J He… - American journal of …, 2019 - ncbi.nlm.nih.gov
Nowadays, the bacterial drug resistance leads to serious healthy problem worldwide due to
the long-term use and the abuse of traditional antibiotics result in drug resistance of bacteria …
the long-term use and the abuse of traditional antibiotics result in drug resistance of bacteria …
Mini review on antimicrobial peptides, sources, mechanism and recent applications
Antimicrobial peptides in recent years have gained increased interest among scientists,
health professionals and the pharmaceutical companies owing to their therapeutic potential …
health professionals and the pharmaceutical companies owing to their therapeutic potential …
Clinical applications and anticancer effects of antimicrobial peptides: from bench to bedside
Cancer is a multifaceted global health issue and one of the leading causes of death
worldwide. In recent years, medical science has achieved great advances in the diagnosis …
worldwide. In recent years, medical science has achieved great advances in the diagnosis …
[HTML][HTML] An update on antimicrobial peptides (AMPs) and their delivery strategies for wound infections
Bacterial infections occur when wound healing fails to reach the final stage of healing, which
is usually hindered by the presence of different pathogens. Different topical antimicrobial …
is usually hindered by the presence of different pathogens. Different topical antimicrobial …
Mechanisms of action of antimicrobial peptides ToAP2 and NDBP-5.7 against Candida albicans planktonic and biofilm cells
J do Nascimento Dias, C de Souza Silva… - Scientific reports, 2020 - nature.com
Candida albicans is a major cause of human infections, ranging from relatively simple to
treat skin and mucosal diseases to systemic life-threatening invasive candidiasis. Fungal …
treat skin and mucosal diseases to systemic life-threatening invasive candidiasis. Fungal …
d-Amino acids in antimicrobial peptides: a potential approach to treat and combat antimicrobial resistance
S Kapil, V Sharma - Canadian journal of microbiology, 2021 - cdnsciencepub.com
Antimicrobial resistance is one of the leading challenges in the human healthcare segment.
Advances in antimicrobial resistance have triggered exploration of natural alternatives to …
Advances in antimicrobial resistance have triggered exploration of natural alternatives to …
Recent strategies for inhibiting multidrug-resistant and β-lactamase producing bacteria: A review
Abstract β-lactam antibiotics are one of the most commonly used drugs for treating bacterial
infections, but their clinical effectiveness has been severely affected with bacteria …
infections, but their clinical effectiveness has been severely affected with bacteria …
In vitro activity of the antimicrobial peptides h-Lf1-11, MSI-78, LL-37, fengycin 2B, and magainin-2 against clinically important bacteria
LB Denardi, P de Arruda Trindade, C Weiblen… - Brazilian journal of …, 2022 - Springer
We investigated the antibacterial activity of the antimicrobial peptides h-Lf1-11, MSI-78, LL-
37, fengycin 2B, and magainin-2. The minimum inhibitory concentration (MIC) was …
37, fengycin 2B, and magainin-2. The minimum inhibitory concentration (MIC) was …
Comparative Antimicrobial Activity of Hp404 Peptide and Its Analogs against Acinetobacter baumannii
MJ Hong, MK Kim, Y Park - International journal of molecular sciences, 2021 - mdpi.com
An amphipathic α-helical peptide, Hp1404, was isolated from the venomous gland of the
scorpion Heterometrus petersii. Hp1404 exhibits antimicrobial activity against methicillin …
scorpion Heterometrus petersii. Hp1404 exhibits antimicrobial activity against methicillin …
Antimalarial agents as therapeutic tools against toxoplasmosis—a short bridge between two distant illnesses
Toxoplasmosis is an infectious disease with paramount impact worldwide, affecting many
vulnerable populations and representing a significant matter of concern. Current therapies …
vulnerable populations and representing a significant matter of concern. Current therapies …